Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balanced Crystalloids vs Normal Saline in Sepsis
NCT03685214Unknown
- Start
- Mar 2019
- Primary completion
- Apr 2021
- Modality
- NPI (Non-Pharmacological Intervention), SOLN (Solution)
- Countries
- 1
01
Overview
Randomised, open-label trial of ringer's acetate in sepsis (2 arms). Primary endpoints: Development of kidney injury as defined by the KDIGO criteria at 5 days and Need of renal replacement treatment at 15 days. Status: unknown.
02
Drugs
ringer's acetate
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT03685214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03685214.